6.1 Brevetto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 5.365
NA - Nord America 5.103
AS - Asia 1.711
SA - Sud America 137
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 4
OC - Oceania 1
Totale 12.342
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.088
IT - Italia 1.501
SE - Svezia 1.126
IE - Irlanda 759
RU - Federazione Russa 562
TR - Turchia 512
SG - Singapore 486
CN - Cina 482
DE - Germania 438
UA - Ucraina 371
GB - Regno Unito 236
VN - Vietnam 150
FI - Finlandia 130
BR - Brasile 125
CH - Svizzera 114
AT - Austria 47
EU - Europa 21
AE - Emirati Arabi Uniti 20
FR - Francia 19
AL - Albania 17
BE - Belgio 17
CA - Canada 13
NL - Olanda 13
HK - Hong Kong 12
PK - Pakistan 8
IQ - Iraq 7
KR - Corea 7
IN - India 5
UZ - Uzbekistan 4
AR - Argentina 3
BG - Bulgaria 3
JP - Giappone 3
KG - Kirghizistan 3
LT - Lituania 3
PE - Perù 3
BD - Bangladesh 2
HU - Ungheria 2
IR - Iran 2
MA - Marocco 2
UY - Uruguay 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
ES - Italia 1
GE - Georgia 1
IL - Israele 1
IM - Isola di Man 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
ME - Montenegro 1
MX - Messico 1
OM - Oman 1
PL - Polonia 1
PY - Paraguay 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 12.342
Salva come PNG Salva come JPEG
Città #
Pisa 979
Jacksonville 864
Dublin 759
Chandler 751
Boardman 459
Izmir 404
Wilmington 365
Ann Arbor 328
Ashburn 278
Singapore 224
Düsseldorf 185
Millbury 176
Boston 169
Moscow 162
Dong Ket 150
San Mateo 116
Mestre 108
Istanbul 105
Beijing 98
Bern 92
Woodbridge 85
Seattle 84
Dearborn 79
Bremen 76
Lawrence 71
Ogden 66
Scuola 65
The Dalles 63
Princeton 55
Milan 52
Saint Petersburg 43
Vienna 41
Guangzhou 40
San Giuliano Terme 39
Chicago 35
New York 34
Los Angeles 31
Shanghai 24
North Bergen 22
Nanjing 21
Padova 21
Helsinki 18
Kunming 18
Rome 18
Zurich 18
Hefei 17
Santa Clara 17
Brussels 16
Washington 16
Wuhan 16
Andover 14
Jiaxing 14
Norwalk 14
Bientina 12
Yiwu 12
Cambridge 11
Fairfield 11
São Paulo 11
Florence 10
Munich 10
Nuremberg 9
Wuxi 9
Hong Kong 8
Jinan 8
San Diego 8
Frankfurt am Main 7
Martignacco 7
Nanchang 7
Seoul 7
Toronto 7
Verona 7
Lauterbourg 6
Rio de Janeiro 6
Serra 6
Berlin 5
Centrale 5
Hangzhou 5
Jinhua 5
Shaoxing 5
Auburn Hills 4
Baghdad 4
Cascina 4
Chengdu 4
Graz 4
Houston 4
Lausanne 4
Shenzhen 4
Tashkent 4
Tiantai Chengguanzhen 4
Zhengzhou 4
Betim 3
Bishkek 3
Brescia 3
Chantilly 3
Curitiba 3
Fuzhou 3
Genoa 3
Gorizia 3
Lahore 3
Leawood 3
Totale 8.293
Salva come PNG Salva come JPEG
Nome #
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 206
METODO PER ANIMARE SULLO SCHERMO DI UN COMPUTER UNA PENNA VIRTUALE CHE SCRIVE E DISEGNA 205
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 193
Liquid motion control device for Lab-on-a-Chip (LOC) system of e.g. food analysis apparatus, has control unit with acoustic resonator that reflects surface acoustic wave (SAW) when quantity of liquid is present within acoustic resonator 193
METHOD TO ANIMATE ON A COMPUTER SCREEN A VIRTUAL PEN WHICH WRITES AND DRAWS 185
Composti particolarmente catalizzatori di poliuretani 173
COMPOSIZIONI IN GRADO DI PREVENIRE EVENTI NEURODEGENERATIVI E METODO PER SAGGIARNE L'ATTIVITA' 160
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 159
Dispositivo automatizzato per la riabilitazione motoria e per la valutazione della funzionalità degli arti anteriori in modelli animali 157
Vettore per il rilascio di un agente attivo, fotoscindibile per irraggiamento nel visibile 156
Method and device for measuring position and mass 156
ANIMALI TRANSGENICI NON UMANI ANTI-NGF 148
Bucket brigade address decoding architecture for classical and quantum random access memories 146
Superfici funzionali con morfologia controllata sulla scala nanometrica atte a modulare l’adesione, vitalità e proliferazione di cellule 146
METHOD TO SYNCHRONIZE AUDIO AND GRAPHICS IN A MULTIMEDIA PRESENTATION 144
NACYLUREA COMPOUNDS FOR PREPARING POLYURETHANES 141
null 129
NOVEL ANALGESIC TREATMENT WITH PROLONGED EFFECT 126
Laser circolari a semiconduttore con reticoli per emissione verticale 126
COMPOSITIONS ABLE TO PREVENT NEURODEGENERATIVE PROCESSES AND METHODS OF ASSAYING THE SAME 124
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 123
MUTEINS OF HNGF, THERAPEUTIC USES AND PHARMACEUTICAL COMPOSITIONS 123
Use of an anti-NGF IgG4 isotype antibody for treating and/or preventing chronic pain 122
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 119
VECTOR FOR THE RELEASE OF AN ACTIVE AGENT WHICH IS PHOTOCLEAVABLE BY IRRADIATION IN THE VISIBLE 118
Method for the humanization of antibodies and humanized antibodies thereby obtained 117
Method for Ensuring privacy while querying a database by using quantum superpositions and multiple responses 115
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 115
Metodo non invasivo per misurare il contenuto idrico assoluto di una foglia 114
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 113
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 113
Method for the humanization of antibodies and humanized antibodies thereby obtained 112
INTRACELLULAR ANTIBODIES 110
ANIMALI TRANSGENICI NON UMANI ESPRIMENTI ANTICORPI ANTI-NGF. 109
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 108
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 107
Method for the humanization of antibodies and humanized antibodies thereby obtained. 107
Method for the potentiation of opioid analgesics effects on pain 106
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 104
Humanized anti-NGF antibodies 104
Intracellular selection 104
Method of identifying a consensus sequence for intracellular antibodies 104
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 103
METODO PER IDENTIFICARE UN INIBITORE SELETTIVO DEL PRONGF E INIBITORI SELEZIONATI CON ESSO 103
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 103
Non human transgenic animal as a model of neurodegenerative diseases and for the early diagnosis thereof 103
Method for the potentiation of opioid analgesics effects on pain 102
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 102
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 101
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT. 101
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 101
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 101
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 101
NGF AND TrkA RECEPTOR BINDING INHIBITING MOLECULES AS PROLONGED ANALGESICS 100
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 100
Intracellular selection 100
Method for the humanization of antibodies and humanized antibodies thereby obtained 99
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 99
Selection of intracellular immunoglobulins 99
Nanoresonator structure used as nanosensor for e.g. medical application, comprises conductive material layers and dielectric layer, and is represented by specific circuit with resonant frequency determined by geometrical dimensions 99
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 98
Novel analgesic treatment with prolonged effect 98
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 96
Non-human transgenic animals for the study of neurodegenerative syndromes 96
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 96
Intracellular selection 96
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 95
Selection of intracellular immunoglobulins 95
Humanized anti-NGF antibodies 95
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 95
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 95
TRANSGENIC MICE FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 95
INTRACELLULAR ANTIBODIES 95
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 95
Humanized anti-NGF antibodies 94
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 94
Method for the humanization of antibodies and humanized antibodies thereby obtained. 94
NON-HUMAN TRANSGENIC ANIMALS FOR THE STUDY OF NEURODEGENERATIVE SYNDROMES 94
NON HUMAN TRANSGENIC ANIMAL AS A MODEL OF NEURODEGENERATIVE DISEASES AND FOR THE EARLY DIAGNOSIS THEREOF 93
Method for the humanization of antibodies and humanized antibodies thereby obtained. 93
Selection of intracellular immunoglobulins 93
Method for the humanization of antibodies and humanized antibodies thereby obtained. 93
SELECTION OF INTRACELLULAR IMMUNOGLOBULINS 92
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 92
Novel analgesic treatment with prolonged effect 92
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 92
Method for the humanization of antibodies and humanized antibodies thereby obtained. 91
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 91
METHOD FOR ISOLATING INTRACELLULAR ANTIBODIES ABLE TO NEUTRALIZE PROTEIN INTERACTIONS 91
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TrkA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 91
Selection of intracellular immunoglobulins 91
SEQUENZE CONSENSO PER ANTICORPI INTRACELLULARI E LORO USO 90
METHOD OF IDENTIFYING A CONSENSUS SEQUENCE FOR INTRACELLULAR ANTIBODIES 90
MOLECULES THAT ARE ABLE TO INHIBIT THE BINDING BETWEEN NGF AND THE TRKA RECEPTOR AS ANALGESICS WITH PROLONGED EFFECT 89
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 89
Novel analgesic treatment with prolonged effect 88
Method for the humanization of antibodies and humanized antibodies thereby obtained 88
Molecules that are able to inhibit the binding between NGF and the Trka receptor as analgesics with prolonged effect 88
Selection of intracellular immunoglobulins 88
METHOD FOR IN VIVO IDENTIFICATION OF INTRACELLULAR EPITOPES 85
Totale 11.163
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 0 0 0 0 0 0 0 0 0 0 127 23
2020/20211.736 129 8 355 10 115 153 82 123 134 268 91 268
2021/2022928 123 0 24 125 15 5 10 70 50 58 19 429
2022/20233.520 241 136 136 219 161 380 0 982 1.122 22 38 83
2023/20241.181 209 48 93 31 53 127 18 119 199 22 19 243
2024/20252.024 93 34 178 172 477 14 42 188 657 153 16 0
Totale 12.474